Clonidine reduces blood pressure and heart rate oscillations in hypertensive patients

Area of Science:

• Cardiology
• Pharmacology
• Physiology

Background:

• Essential hypertension is characterized by short-term fluctuations in blood pressure (BP) and heart rate (HR).
• Understanding the autonomic nervous system's role in BP and HR variability is crucial for managing hypertension.

Purpose of the Study:

• To investigate the effects of clonidine on BP and HR variability in men with essential hypertension.
• To explore the underlying mechanisms of clonidine's hypotensive effects, particularly baroreflex sensitivity.

Main Methods:

• A double-blind, crossover, placebo-controlled study involving eight men with essential hypertension.
• Continuous BP and HR monitoring using a Finapres device with spectral analysis via fast Fourier transform.
• Assessment of BP (SAP, DAP, MAP) and HR variability before and after a 150-microgram oral dose of clonidine.

Main Results:

• Clonidine (150 micrograms) significantly reduced BP and HR variability by 21-36.7% after 90 minutes.
• Average BP decreased by 10.6-19.7 mm Hg and HR by 1.0 beat/min.
• Spectral analysis revealed clonidine reduced BP and HR oscillations in the mid-frequency range (66-129 mHz), linked to autonomic activity.

Conclusions:

• Clonidine effectively reduces BP and HR variability in hypertensive individuals.
• The findings suggest clonidine enhances baroreflex sensitivity, leading to improved BP and HR regulation.
• Clonidine's impact on autonomic nervous system activity is a key factor in its therapeutic effects.